Wallnis Pharmas Private Limited

Wallnis Pharmas Private Limited - chemicals in Noida, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U24230UP2021PTC150038 Incorporated 03 August 2021 ROC Kanpur HQ Noida, Uttar Pradesh, India
Active Private Limited Company chemicals MSME · Micro
Revenue · FY 2025
₹17.31 Lakh
▼ 19% YoY
Net loss · FY 2025
₹87,393
Net margin -5%
EBITDA · FY 2025
-₹60,099
EBITDA margin -3.5%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Wallnis Pharmas Private Limited

Data last updated:

Wallnis Pharmas Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 03 August 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24230UP2021PTC150038. Its GSTIN is 20AADCW0220A1ZH (Jharkhand).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Nalin Ranjan Pandey and Mayank Kumar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 208 First Floor E Block Sector 63, Noida, Uttar Pradesh, India – 201307.

As per the financials filed for FY 2025, the company reported a revenue of ₹17.31 Lakh, a decline of 19% compared to the previous year. For the same year it recorded a net loss of ₹87,393 (net margin -5%) and EBITDA of -₹60,099 (EBITDA margin -3.5%). Revenue has grown at a compounded annual rate (CAGR) of 73% over three years.

Wallnis Pharmas Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-28-0024670).

Company details

CIN U24230UP2021PTC150038
Registration Number 150038
Incorporation Date 03 August 2021
ROC Kanpur
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-UP-28-0024670

Recognitions & Rankings of Wallnis Pharmas

MSME (Udyam registered) Ministry of MSME
Category
Micro (2021-22)
Udyam number
UDYAM-UP-28-0024670

Contact details

Wallnis Pharmas Private Limited's registered office is in Noida, Uttar Pradesh. Its e-mail address is in the company report.

  • Email
  • Registered Address
    E – 208 First Floor E Block Sector 63, Noida, Uttar Pradesh, India – 201307
  • Industry
    Chemicals, Manufacturing, Other Chemical Product

To see the full contact details of Wallnis Pharmas Private Limited, buy the company report.

Comprehensive company report
Wallnis Pharmas Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Wallnis Pharmas is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Wallnis Pharmas Private Limited, buy the company report.

Financials of Wallnis Pharmas Private Limited

FY 2025 filings available

Wallnis Pharmas Private Limited reported revenue of ₹17.31 Lakh (down 19% YoY) for FY 2025.

Revenue · FY 2025
₹17.31 Lakh ▼ 19%
Net loss · FY 2025
₹87,393 margin -5%
EBITDA · FY 2025
-₹60,099 margin -3.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 19%
3 years · compounded
▲ 73%
EBITDA CAGR growth
1 year
▼ 359%
3 years · compounded
▲ 51%

Revenue fell 19% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 73%. EBITDA fell 359% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹60,099
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹87,393
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin-3.5%
Net Profit Margin-5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Wallnis Pharmas Private Limited, buy the company report.

Board of directors of Wallnis Pharmas Private Limited

Wallnis Pharmas has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Nalin Ranjan PandeyDirector03 Aug 20215 Years 3 MonthsCurrent
Mayank KumarDirector03 Aug 20215 Years 3 MonthsCurrent

Peer comparison

Wallnis Pharmas Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Securic Technohouse IT Solutions Private Limited₹17.38 Lakh (FY 2023)-7.0%Hyderabad, Telangana, India
Da Crete Chem Private Limited₹17.37 Lakh (FY 2022)573.0%Hyderabad, Telangana, India
Kleanair Enviro Systems Private Limited₹17.36 Lakh (FY 2025)20.0%Bangalore, Karnataka, India
Silver Cap Works Private Limited₹17.35 Lakh (FY 2025)66.0%Sivakasi, Tamil Nadu, India
Anand Herbs India Private Limited₹17.31 Lakh (FY 2016)13.0%Bhagalpur, Bihar, India
Wallnis Pharmas Private Limitedthis company₹17.31 Lakh (FY 2025)-₹87,393-5%-19.0%Noida, Uttar Pradesh, India
Himed Lifesciences Private Limited₹17.29 Lakh (FY 2025)7.0%Kolhapur, Maharashtra, India
Mitranirmal Meditech Private Limited₹17.27 Lakh (FY 2025)-28.0%Nachane, Maharashtra, India
SMN Pharma Private Limited₹17.27 Lakh (FY 2025)393.0%Chennai, Tamil Nadu, India
Modern Health Products Private Limited₹17.26 Lakh (FY 2025)80.0%Gwalior, Madhya Pradesh, India
Zipka Pharmaceuticals Private Limited₹17.24 Lakh (FY 2024)429.0%Lucknow, Uttar Pradesh, India

To see the full peer comparison of Wallnis Pharmas Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Wallnis Pharmas Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Wallnis Pharmas has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
20AADCW0220A1ZHJharkhandActive06 Sep 2021

To see the full GST registrations and return filing status of Wallnis Pharmas Private Limited, buy the company report.

Recent activity

Wallnis Pharmas Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Mayank Kumar was appointed as Director on 03 Aug 2021.

AGM
Wallnis Pharmas Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Wallnis Pharmas Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Appointed
Mayank Kumar was appointed as Director.
Appointed
Nalin Ranjan Pandey was appointed as Director.
Incorporation
03 Aug 2021
Wallnis Pharmas Private Limited was registered on 03 Aug 2021 with Roc Kanpur & aged 5 years 3 months as per MCA records.

Frequently asked questions

Wallnis Pharmas is an active private limited company based in Noida, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 03 August 2021 (5+ years old) and is registered under CIN U24230UP2021PTC150038.

Wallnis Pharmas has 2 current directors:

The latest financial statements of Wallnis Pharmas on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The GSTIN of Wallnis Pharmas is 20AADCW0220A1ZH, registered in Jharkhand.

The CIN (Corporate Identification Number) of Wallnis Pharmas is U24230UP2021PTC150038. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Wallnis Pharmas was incorporated on 03 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Kanpur.

The peers of Wallnis Pharmas by revenue are Securic Technohouse IT Solutions Private Limited, Da Crete Chem Private Limited, Kleanair Enviro Systems Private Limited, Silver Cap Works Private Limited, Anand Herbs India Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Mayank Kumar was appointed as Director on 03 Aug 2021. Nalin Ranjan Pandey was appointed as Director on 03 Aug 2021.

Yes, Wallnis Pharmas is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-28-0024670).

The registered office of Wallnis Pharmas is at E – 208 First Floor E Block Sector 63, Noida, Uttar Pradesh, India – 201307.

Wallnis Pharmas operates in the chemicals industry, in the manufacturing segment.